News

DFG Approves Transregional Collaborative Research Center TRR 417 to Study the Tumor Microenvironment Led by Goethe University Frankfurt in Collaboration with the Universities of Erlangen-Nuremberg and Freiburg, the Georg-Speyer-Haus and the Paul-Ehrlich-Institut

Researchers discover dual role of inflammatory signaling in colorectal cancer

Rían Mc Neill and his colleagues are ready to run for our health and against cancer and raise funds for the Institute.
At Georg-Speyer-Haus, our mission goes beyond the finish line: we are committed to advancing cancer research with the goal of improving patient outcomes by deepening our…

PD Dr. rer. nat. Henner Farin took up his appointment as Heisenberg Professor (W2) for “Experimental Model Systems in Tumor Biology” at the Institute of Tumor Biology and Experimental Therapy at the Georg-Speyer-Haus on January 1, 2025.

Factor in connective tissue cells (ZEB1) modulates the efficacy of immunotherapy in colorectal carcinomas

Recent publication in Nature Reviews Cancer

Georg Speyer House certified for the second time

The German Science and Humanities Council (Wissenschaftsrat) certifies the Georg-Speyer-Haus high expertise in research and translation on the tumor microenvironment

Florian Greten, Director of the Georg-Speyer-Haus and speaker of the LOEWE Centre Frankfurt Cancer Institute is 2023 amongst the prestigious Highly Cited Researchers selected by Claviate (Web of Science). His work on colorectal cancers and especially the tumor microenvironment in the last decade had…

The Georg-Speyer-Haus scientist is accepted into the Heisenberg Program of the German Research Foundation (DFG)

Canan Arkan appointed Professor for Tumor Metabolism at LOEWE-Centre FCI & Georg-Speyer-Haus

Researchers in Frankfurt discover new mechanism of chemotherapy resistance in colon cancer

Researchers identify way to boost tumor-fighting immune cells

#ScienceForUkraine – GSH supports initiative for scientists from Ukraine

HR spotlights tumor research at Georg-Speyer-Haus on World Cancer Day

Inflammatory connective tissue cells decrease response to radiochemotherapy

Appreciation and esteem in their entire scope

Great Award for Director of the Georg-Speyer-Haus

GSH receives audit berufundfamilie certificate

Dr. Medyouf participates in the European Innovative Training Network INTERCEPT-MDS focusing on the shared training and research in Myeloid Diseases.

GSH generates an extensive pharmacological drug library with other institutions and pharmaceutical companies

Prof. Dr. Daniela Krause received the Langener Science Award at the Paul-Ehrlich-Institute for her work on Home is where the bone is – The bone marrow as an innovative therapeutic approach to blood formation. “We are pleased to honour Prof. Daniela Krause, a scientist who is researching innovative…

This year’s 2019 Beug Foundation Metastasis Research Award goes to Dr. Lisa Sevenich for her efforts in studying T-cell responses in brain metastases.

Else Kroener-Fresenius-Foundation funds research project of Prof. Dr. Daniela Krause

Cell Plasticity in Colorectal Carcinogenesis research group under leadership of Prof. Dr. Greten receives extension for additional 3 years

22nd German Future Award goes to the project Protection in the Absence of an Immune System – the Life-Saving Innovation against Dangerous Viruses

About Hind Medyouf

Dr. Medyouf joined the Institute for Tumor Biology and Experimental Therapy in October 2014. Her research is focused on exploring the role of the tumor microenvironment in leukemia and solid cancer metastasis. In particular, the group is investigating the complex cellular…

Ewelina Czlonka receives the José Carreras Leukemia Foundation research grant for her doctoral thesis

Dynamic Formation of Microvillus Inclusions During Enterocyte Differentiation in Munc18-2–Deficient Intestinal Organoids

Joint priority program investigates the development of bone metastases